Clinical trials for AstraZeneca-Oxford's COVID-19 vaccine 'AZD1222' resume in UK after MHRA nod

AstraZeneca has resumed British clinical trials of its COVID-19 vaccine AZD1222, one of the most advanced in development in collaboration with the Oxford University, after receiving the green light from the Medicines Health Regulatory Authority (MHRA) safety watchdog, the company said on Saturday.